Blackstone Ventures is pleased to announce that it has entered into a letter of intent, pursuant to which, subject to receipt of all applicable regulatory and shareholder approvals, the Company has agreed to acquire all of the issued and outstanding securities of Lattice Biologics Inc., a private, arm's length Delaware corporation.
At the request of IIROC, Blackstone Ventures Inc. wishes to confirm that the Company's management is unaware of any material change in the Company's operations that would account for the recent increase in market activity. About Blackstone Blackstone is a mineral exploration company currently undertaking a focused effort to identify, review, and [...]
Blackstone Ventures is pleased to announce the appointment of Mr. Peter Wong to the Board of Directors. Mr. Wong has held a number of progressive senior financial management positions with publicly listed mining and technology companies at the venture, development and operational stages and is currently the Chief Financial Officer for Alterra Power [...]
Blackstone Ventures recently held its 2012 Annual General Meeting in Vancouver. Resolutions passed at the meeting included the re-appointment of Hay and Watson as auditors of Blackstone, approval of Blackstone's incentive stock option plan, and the re-election of Donald McInnes, John Greig, and Tor Falck as Directors. A special resolution [...]
Blackstone Ventures wishes to announce that it has signed an amended option and joint venture agreement with Konnex Resources with respect to Blackstone's Norbotten iron-oxide-copper-gold project located in northern Sweden. Under the terms of the original agreement Blackstone was the operator of the Norbotten Project and Konnex could earn an [...]
